tiprankstipranks
Pluri trading resumes
PremiumThe FlyPluri trading resumes
5M ago
Pluri trading halted, volatility trading pause
Premium
The Fly
Pluri trading halted, volatility trading pause
5M ago
Pluri signs tech transfer, manufacturing agreement with Kadimastem
Premium
The Fly
Pluri signs tech transfer, manufacturing agreement with Kadimastem
5M ago
Pluri announces strategic collaboration with Wilk Technologies
PremiumThe FlyPluri announces strategic collaboration with Wilk Technologies
7M ago
Pluri launches novel immunotherapy platform, announces appointments to SAB
Premium
The Fly
Pluri launches novel immunotherapy platform, announces appointments to SAB
8M ago
Pluri granted U.S. patent for method for expansion of immune cells
Premium
The Fly
Pluri granted U.S. patent for method for expansion of immune cells
9M ago
Pluri selected as CDMO by Remedy Cell for cell-free drug manufacturing
PremiumThe FlyPluri selected as CDMO by Remedy Cell for cell-free drug manufacturing
9M ago
Pluri receives patent approval for 3D bioreactor technology
Premium
The Fly
Pluri receives patent approval for 3D bioreactor technology
10M ago
Pluri appoints James Roosevelt, Jr. to advisory board
Premium
The Fly
Pluri appoints James Roosevelt, Jr. to advisory board
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100